|
|
 |
|
Viewing report
|
|
|
|
Harnessing Patient Power: Strategies For Speeding Drug Approval, Building And Retaining Market Share
Business Insights, Jan 2004, Pages: 110
Relationships between the pharmaceutical industry and patient groups have changed drastically during the past two decades, they are no longer restricted to financial contributions to create goodwill, with no expectation of a measurable return for the company. The management report, Harnessing Patient Power: Strategies for speeding drug approval, building and retaining market share, outlines the developments in pharma-patient group alliances and provides a guide for maximizing their impact across a range of pharma activities: clinical trial recruitment, product launches, CME programs, disease awareness and education initiatives. Advocacy groups are now more aware of how to leverage their influence, but still seek financial assistance, cutting-edge information about clinical trials, new therapies, professional or technical support, and other in-kind contributions that help them better serve their patient communities. The report uses detailed case studies to pinpoint how pharma companies can convert such relationships into important business tools to meet their corporate objectives.
Customers who bought this item also bought
Online Patient Recruitment And Its Impact On Patient Relationship Management
Patient Monitoring Markets
Patient Empowerment: empowered patients can change healthcare outcomes and impact the pharmaceutical industry
eHealth Solutions for Pharma: Strategies for Salesforces, Marketing, Patient Compliance and Clinical Trials
The 2010-2015 Outlook for Patient Scales in India
Pipeline Insight: Disease Modification In Rheumatoid Arthritis - Competition For The Anti-TNF Failure Patient Population Increases
The Business Case for Web 2.0 in Healthcare: Building Brands and Redefining the Patient Experience
North American Home Health Care and Disease Management Markets for Remote Patient Monitoring
Nexium Case Study: Using Public Relations to Reach Diverse Patient Populations and Build Bridges Between Product Generations
UCSF's Management of the Hospitalized Patient
Commercial Insight: Neuropathic Pain - A Plethora of Patient Segmentation and Product Differentiation Opportunities
Designing Patient Communications Programs: Education, Adherence, and Disease Management
|
|
|
|
